It has been demonstrated that almost all of the IR in T2DM patients can be attributed to insulin-stimulated muscle glycogen synthesis defects, resulting from deficiency of insulin-stimulated glucose transport and phosphorylation activity. This evidence concerns the gene INS and type 2 diabetes mellitus.